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Ischemia and reperfusion cause the production of oxygen free radicals. 
These damage grafts or disrupt normal vascular homeostatic mechanisms, 
with a parallel reduction in endothelial nitric oxide and adenosine 3',5'- 
cyclic monophosphate l vels. We hypothesized that lung preservation 
failure may be related to these events. To improve lung preservation, we 
prepared a new ET-Kyoto solution, which contains N-acetylcysteine (a 
radical scavenger), nitroglycerin (to elevate the nitric oxide level), and 
dibutyryl adenosine 3',5'-cyclic monophosphate (to elevate the adenosine 
3',5'-cyclic monophosphate l vel) and examined its efficacy in a canine 
single-lung transplantation model. Lungs were flushed with new ET-Kyoto 
solution (group I, n = 9), basal ET-Kyoto solution (group II, n = 6) ,  basal 
ETlKyoto solution plus ethanol and propylene glycol (solvents of nitroglyc- 
erin; group II I ,  n = 6), or low-potassium dextran glucose solution (group 
IV, n = 6), and stored at 4°C for 30 hours. After left single-lung 
transplantation, the right main bronchus and right pulmonary artery were 
ligated and the functions of the transplanted lung were assessed for 6 
hours. Arterial oxygen tension was significantly higher in group I than in 
groups II, I I I ,  and IV (p < 0.05). Peak inspiratory pressure and wet-to-dry 
lung weight ratio were significantly lower in group I than in groups I I  and 
IV (p < 0.01). Histologic and ultrastructural studies showed better 
preservation i  group I than in groups II, I I I ,  and IV. We conclude that the 
new ET-Kyoto solution provides enhanced 30-hour lung preservation. 
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T he shortage of suitable donor lungs still limits the widespread application of lung transplantation 
among patients with end-stage lung diseases) Cur- 
rent commercial preservation solutions used in clin- 
ical lung transplantation have a maximum safe isch- 
emic time of 10 hours. 2' 3 Because the lung has a 
delicate alveolar-capillary membrane network, it is 
important o maintain the integrity of the pulmo- 
nary vascular endothelium during preservation and 
transplantation. In our previous study, we demon- 
strated by scanning electron microscopy (SEM) and 
transmission electron microscopy a statistically sig- 
nificant correlation between the functions of the 
transplanted lung and the structures of the vascular 
endothelial cells. 4 In a series of studies, ischemia 
and reperfusion were shown to produce many oxy- 
gen free radicals, which caused pulmonary vascular 
endothelial cell damage. 5'6 Furthermore, ischemia 
and reperfusion reduce endothelial nitric oxide 
(NO) and adenosine 3',5'-cyclic monophosphate 
(cAMP) levels, 7' s both of which play critical roles in 
maintaining the vascular endothelial barrier func- 
tion and in preventing the adherence to vascular 
endothelial cells of neutrophils and platelets. 8-12 
Many reports have shown that oxygen-free radical 
scavengers, uch as N-acetylcysteine, protect pulmo- 
nary endothelial cells from ischemia-reperfusion 
injury. Agents such as nitroglycerin or dibutyryl 
cAMP (db-cAMP), which elevate NO or cAMP 
levels, maintain graft vascular homeostasis during 
ischemia and reperfusion. 5' 6,13-17 We hypothesized 
that adequate supplementation of a preservation 
solution with these agents might enhance lung pres- 
ervation for transplantation. We prepared a new 
ET-Kyoto solution (new ET-K) in which N-acetyl- 
cysteine, nitroglycerin, and db-cAMP are added to 
the previously reported ET-Kyoto solution (ET- 
K),ls, 19 and examined its efficacy for 30-hour pres- 
ervation of canine lungs prepared for transplanta- 
tion. 
Materials and methods 
Solutions. The compositions ofthe solutions are shown 
in Table I. N-acetylcysteine was supplied by Eisai Co., Ltd. 
(Tokyo, Japan), nitroglycerin was purchased from the 
Green Cross Corporation (Osaka, Japan), db-cAMP was 
purchased from Daiiti Pharmaceutical Co., Ltd. (Tokyo, 
Japan), ethanol was purchased from Ueno Kagaku Inc. 
(Kyoto, Japan), and propylene glycol was purchased from 
Nacalai Tesque Inc. (Kyoto, Japan). ET-K (osmolarity 
366 mOsm/L) was prepared by us as described else- 
wherejS, 19 New ET-K was prepared just before the donor 
lung was flushed. Ethanol and propylene glycol were 
included new ET-K as solvents of nitroglycerin, and the 
osmolarity of new ET-K was 598 mOsm/L. To determine 
whether these two solvents and the osmolarity of new 
ET-K would have any effect on lung preservation, we 
prepared ET-K with added ethanol and propylene glycol 
(ET-KA), the osmolarity of which was 583 mOsm/L. The 
low-potassium dextran glucose solution (LPDG) used in 
this study was prepared as described in previous re- 
ports.2O, 21 The compositions of these solutions were ana- 
lyzed before the experiments. 
Experimental groups. Twenty-seven pairs of size- 
matched adult mongrel dogs weighing 7.7 to 15.7 kg were 
randomly assigned to four experimental groups. In group 
I (n = 9), donor lungs were flushed and stored with new 
ET-K, in group II (n = 6) donor lungs were flushed and 
stored with ET-K, in group III (n = 6)donor lungs were 
flushed and stored with ET-KA, and in group IV (n = 6) 
donor lungs were flushed and stored with LPDG. 
Anesthesia. Induction and maintenance of anesthesia 
were conducted as described previously. 18' 19, 22 Both the 
donor animals and the recipient animals were ventilated 
with an inspired oxygen fraction of 0.5 at a tidal volume of 
20 ml/kg, a respiratory rate of 15 breaths/rain, and a 
positive end-expiratory pressure of 5 cm H20. During 
operative procedures, nitrous oxide with 0.5% to 1.0% 
halothane was used. 
Donor procedure. A right femoral venous catheter 
(Swan-Ganz catheter; Baxter Healthcare Corp., Edwards 
Div., Irvine, Calif.) and a right femoral arterial catheter 
were introduced. Arterial blood gases, peak inspiratory 
pressure, systemic hemodynamics (cardiac output [CO], 
systemic blood pressure), and pulmonary hemodynamics 
(pulmonary arterial pressure [PAP], pulmonary capillary 
wedge pressure [PCWP]) were measured. Pulmonary vas- 
cular resistance (PVR) was calculated as follows: PVR = 
[(PAP - PCWP)/CO] × (80 dyne" sec'cm-5). After 
median sternotomy, the azygos vein was transected and 
the superior and inferior venae cavae, aorta, and pulmo- 
nary artery were encircled. After systemic heparinization 
(200 U/kg), the main pulmonary artery was cannulated 
with a 5 mm diameter cannula through a 3-0 Prolene 
purse-string suture (Ethicon, Inc., Somerville, N.J.). A 
large bolus (25 /xg/kg) of prostaglandin E 1 was injected 
into the right ventricular outflow tract. When the systemic 
systolic pressure declined by at least 40%, the superior 
and inferior venae cavae and the aorta were transected 
and the proximal pulmonary artery was ligated. The left 
atrial appendage was amputated, and the lungs were 
inflated to a maximum inspiratory pressure until all atel- 
ectasis had been eliminated. The pulmonary artery was 
flushed by gravity from a height of 50 cm with 70 ml/kg 
cold (4 ° C) perfusate (new ET-K, ET-K, ET-KA, or 
LPDG). Ventilation of the lungs was continued uring 
pulmonary artery flushing, and the duration of flushing 
was recorded. The defect at the cannula insertion site in 
the pulmonary artery was closed after removal of the 
cannula, and the left atrial appendage was ligated. At an 
endotracheal pressure of 20 cm HaO, the trachea was 
clamped and the heart-lung block was excised with mini- 
mal handling of both lungs. The block was then placed in 
a sterile plastic bag containing 1000 ml of the correspond- 
ing cold solution with 400,000 U penicillin (Meiji Seika, 
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Table I. Composition of preservation solutions 
New ET-K ET-K ET-KA LPDG 
Sodium (mmol/L) 107 100 99 165 
Potassium (mmol/L) 42 44 43 4 
Magnesium (mmol/L) - -  - -  - -  2 
Chloride (mmol/L) - -  - -  - -  101 
Sulfate (mmol/L) - -  - -  - -  2 
Phosphate (retool/L) 24 25 25 34 
Gluconate (mmol/L) 97 100 99 - -  
Glucose (mmol/L) - -  - -  - -  56 
Trehalose (mmol/L) 117 120 119 - -  
Dextran 40 (gm/L) - -  - -  - -  20 
Hydroxyethyl starch (gm/L) 29 30 30 - -  
N-acetylcysteine (mmol/L) 10 - -  - -  - -  
db-cAMP (mmol/L) 2 - -  - -  - -  
Nitroglycerin (mmol/L) 0.44 - -  - -  - -  
Ethanol* (mmol/L) 96 - -  96 - -  
Propyleneglycol* (retool/L) 76 - -  76 - -  
pH 7.4 7.4 7.4 7.4 
Osmolarity (mOsm/L)  598 366 583 335 
*Solvent of nitroglycerin. 
Ltd., Tokyo, Japan) and stored at 4 ° C for 30 hours. After 
cold preservation for 30 hours, parts of the apical, medial, 
and lateral basal segments of the right donor lung were 
excised for SEM examination by two histopathologists 
who were unaware of the preservation solutions used. 
Recipient procedure. Recipients were anesthetized, 
and Swan-Ganz and arterial catheters were introduced as 
in the donor procedure. None of the recipients received 
heparin. Arterial blood gases, peak inspiratory pressure, 
and systemic and pulmonary hemodynamic data (as listed 
in donor procedure) were recorded. Immediately after 
pneumonectomy, parts of the anterior and posterior basal 
segments of the resected native left lung were excised and 
air-dried at 70°C for 7 days, and the wet-to-dry lung 
weight ratio was calculated. Left single-lung transplanta- 
tion was performed as described elsewhere, is'19, 22 Anas- 
tomoses were performed in the following order: left 
atrium, left main bronchus, and left pulmonary artery. 
After transplantation, the right main bronchus and the 
right pulmonary artery were ligated 30 minutes after 
reperfusion, after the tidal volume had been reduced to 
two thirds. Arterial blood gases, peak inspiratory pressure, 
PAP, and systemic blood pressure were recorded 1, 2, 3, 4, 
5, and 6 hours after reperfusion. CO and left atrial 
pressure (LAP) were recorded 6 hours after reperfusion. 
PVR was calculated as follows: PVR = [(PAP - LAP)/ 
CO] × 80 dyne-sec, cm -5. After the final assessments, 
the animals were killed. Parts of the anterior and posterior 
basal segments of the transplanted lung were excised and 
air-dried at 70°C for 7 days, and the wet-to-dry lung 
weight ratio was calculated. One piece from the apical 
posterior segment and another piece from the lateral 
basal segment of the transplanted left lung were excised 
for histologic findings by two histopathologists who were 
unaware of the preservation solutions used. 
Table II. Donor lung data 
Group I Group II Group III Group IV 
(n =9) (n = 6) (n =6) (n =6) 
Flushing time 71 _+ 6 98 _+ 16 85 -- 10 64 _+ 8 
(sec)* 
Cold ischemic time 1802 _+ 9 1803 _+ 8 1799 _+ 10 1808 _+ 3 
(min) * 
Warm ischemic time 67 -+ 2 59 _+ 4 63 -+ 8 67 -+ 6 
(rain)* 
All values expressed as mean -- standard error of the mean. 
*No significant differences among the four groups. 
Statistics. Statistical analysis of the data was performed 
by analysis of variance and Scheffe's multiple comparison 
test. A p value less than 0.05 was considered significant. 
All data are expressed as mean (+_ standard error of the 
mean). 
Animal care. All animals received humane care in com- 
pliance with the "Principles of Laboratory Animal Care" 
formulated by the National Society for Medical Research 
and the "Guide for the Care and Use of Laboratory Ani- 
mals" prepared by the Institute of Laboratory Animal Re- 
sources and published by the National Institutes of Health 
(NIH Publication No. 86-23, revised 1985). 
Results 
Donor and recipient data. Flushing time, cold 
ischemic time, and warm ischemic time did not differ 
significantly among the four groups (Table II). The 
quality of flushing, according to subjective criteria 
such as rapid blanching and absence of mottling, was 
equivalent in the four groups. No significant differ- 
ences were detected among the four groups with 
respect o arterial oxygen tension, peak inspiratory 
pressure, or PVR before harvesting or transplanta- 
tion. 
After left single-lung transplantation, the right 
pulmonary artery and right main bronchus were 
ligated 30 minutes after reperfusion; survival of the 
recipient animal thus depended solely on the left 
transplanted lung. All but two animals survived the 
final assessments. One animal in group I I I  and one 
in group IV died after assessment, 3 hours after 
reperfusion. 
Arterial blood gas analysis. The arterial oxygen 
tension of the transplanted lungs preserved with new 
ET-K in group I was uniformly excellent during the 6 
hours of measurement and was significantly higher 
than that in group II with ET-K, group III with 
ET-KA, or group IV with LPDG (Fig. 1). Decreases in
arterial oxygen tension were found starting 1 hour 
after reperfusion in groups II, III, and IV. 
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Fig. 1. Arterial oxygen tension (Pao2) of transplanted lungs (inspired oxygen fraction 0.5). Filled circles, 
Group I (new ET-K); open squares, group II (ET-K); open triangles, group III (ET-KA); open diamond, 
group IV (LPDG). Asterisk indicatesp < 0.05, group I versus group III or IV; double asterisk indicatesp < 
0.01, group I versus group II or IV, p < 0.05, group I versus group III; dagger indicates p < 0.01, group I
versus group II, III, or IV; double dagger indicates p < 0.05, group I versus group II, III, or IV. 
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Fig. 2. Peak inspiratory pressure (PIP) of transplanted lungs. Filled circles, Group I (new ET-K); open 
squares, group II (ET-K); open triangles, group III (ET-KA); open diamond, group IV (LPDG); PRE-OP, 
before operation on recipients.Asterisk indicatesp < 0.05, group I versus group II; double asterisk indicates 
p < 0.01, group I versus group II or IV. 
Peak inspiratory pressure. The peak inspiratory 
pressure in group I was stable during the 6 hours 
of assessment and was significantly lower than 
that in group I I  or IV after 5 to 6 hours of  
reperfusion (p < 0.05 vs group I I  5 hours after 
reperfusion, p < 0.01 vs group I I  or IV 6 hours 
after reperfusion; Fig. 2). 
PVR. After 6 hours of reperfusion, the PVR of the 
transplanted lung was 2164 + 260 dyne. sec. cm -5 in 
group I, 3057 _+ 84 dyne.sec,  cm -s in group II, 
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Fig. 3. Wet-to-dry (W/D) lung weight ratio of transplanted lungs. Asterisk indicates p < 0.01, control 
(resected native left lungs) versus group II (ET-K), III (ET-KA), or IV (LPDG). Dagger indicates p < 0.01 
group I (new ET-K) versus group II or IV. No significant difference was observed between control group 
and group I or between groups I and III. 
2454 _ 240 dyne- sec. cm -5 in group III, and 2739 _+ 
267 dyne.sec, cm -5 in group IV. There were no 
significant differences among the four groups. 
Wet-to-dry lung weight ratio. The wet-to-dry lung 
weight ratios of transplanted lungs in each group are 
shown in Fig. 3. The wet-to-dry lung weight ratio of the 
transplanted lungs in group I was 4.8 _+ 0.2, almost he 
same as that of the resected native left lungs (4.7 _+ 0.2, 
n = 6). In contrast, he wet-to-dry lung weight ratios in 
the other three groups were significantly increased 
(p < 0.01 vs resected native left lungs). Significant 
differences were observed between group I and group 
II or group IV (p < 0.01). 
Histologic findings. Histologic examination 
showed that the transplanted lungs in group I reper- 
fused for 6 hours were essentially normal in structure, 
with no sign of pulmonary edema. In contrast, evi- 
dence of pulmonary edema (exudate accumulation i
alveoli and thickening of the intraalveolar septa) was 
observed in all animals in groups II, III, and IV. 
SEM examination. SEM study after 30 hours of 
cold storage revealed that donor lungs preserved 
with new ET-K (group I) showed essentially normal 
pulmonary arterial endothelial structures (Fig. 4,A). 
In contrast, significant pulmonary arterial endothe- 
lial cell swelling and protrusion were observed in 
group II (Fig. 4, B), group III (Fig. 4, C), and group 
IV (Fig. 4, D). 
Discussion 
In this study, the lungs preserved in new ET-K 
showed essentially normal ultrastructures in SEM ex- 
aminations after 30 hours of cold storage. The trans- 
planted lungs preserved in new ET-K functioned well. 
In lung preservation and transplantation proce- 
dures, pulmonary vascular endothelial cells suffer 
heavy oxidant injury from extracellular nd intracel- 
lular free oxygen radicals, which are produced in 
vascular endothelial cells and in leukocytes. 5' 14, 23 
N-acetylcysteine is a powerful membrane-penetrat- 
ing scavenger of reactive oxygen species, such as 
hydrogen peroxide, hydroxyl radical, superoxide, 
and hypochlorous acid. a4 It reduces extracellular 
and intracellular radicals directly or by replenish- 
ment of cysteine and glutathioneY Sala and associ- 
ates 6 reported that N-acetylcysteine protects pulmo- 
nary vascular endothelial cells against damage by 
oxygen free radical. The protective action of N- 
acetylcysteine against ischemia-reperfusion injury of 
transplanted lungs was reported in our previous 
study. 13 NO and cAMP are intercellular and intra- 
cellular second messengers with important roles 
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Fig. 4. Representative SEM photomicrographs of pulmonary arterial endothelium of preserved donor 
lungs. A, Essentially normal endothelial structures are se nin group I. Significant endothelial cell swelling 
and protrusion are se n in groups II (B), group III (C), and group IV (D). Lines indicate 5/zm. 
in the control of vascular homeostasis and in pre- 
venting the production of oxygen free radicals in 
leukocytes. 8-12'23'26 During ischemia and reperfu- 
sion, both the NO and cAMP levels in vascular 
endothelial cells are reduced, 7 s leading to in- 
creased endothelial cell permeability, induced pro- 
coagulant activity, and leukocyte infiltration. 17' 27, 28 
Nitroglycerin is a precursor of NO that replenishes 
NO in the grafts during ischemia nd reperfusion. 
Naka and associates 15 reported that nitroglycerin 
supplementation n the preservation solution signif- 
icantly improved the functions of transplanted lungs 
preserved in this solution. On the other hand, 
db-cAMP, a membrane-penetrating cAMP analog, 
raises the cAMP level either by being converted 
directly to cAMP or by inhibiting phosphodiesterase 
activity to prevent cAMP catabolism. Adkins and 
associates 16 reported that db-cAMP either prevents 
an increase in pulmonary vascular permeability 
caused by ischemia-reperfusion injury or inhibits the 
ability of neutrophils to damage ndothelial cells 
through amechanism involving an increase in intra- 
cellular levels of cAMP. In this study, lungs pre- 
served in new ET-K, which contains N-acetylcys- 
teine, nitroglycerin, and db-cAMP, had essentially 
normal vascular endothelial structures and histo- 
logic structures and had significantly improved oxy- 
genation-better than those of lungs preserved in 
basal ET-K. These results uggest that the combina- 
tion of these components is important in maintain- 
ing the integrity of the pulmonary vascular endothe- 
lium and potentiating pulmonary function. 
Further studies are necessary to determine the 
effectiveness of each of these components in long- 
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term lung preservation. Oz and associates 17 re- 
por ted  that nitroglycerin and db-cAMP in the pres- 
ervat ion solut ion were effective in cardiac storage, 
but they did not note any effect of N-acetylcysteine. 
Because their concentrat ion of N-acetylcysteine was 
only a twentieth of that in our new ET-K, the 
effectiveness of N-acetylcysteine could not be ruled 
out in our study. It has been reported that nitroglyc- 
erin or db-cAMP prevents an increase in PVR after 
short - term lung ischemiaJ  5' 16 In this study, how- 
ever, we did not observe significant differences in 
PVR of t ransplanted lungs preserved in the tested 
solutions; nitroglycerin and db-cAMP in new ET-K  
do not seem to cause vasodi lat ion during relatively 
long-term lung preservation. 
In this study, we compared new ET-K with ET -KA 
to which we added ethanol and propylene glycol in the 
same concentrations. Both solutions have higher os- 
molarity than that of basal ET-K. In this study, ET -KA 
did not improve lung preservation as well as did new 
ET-K; the lungs preserved in ET -KA showed poor 
pulmonary function and histologic and ultrastructural 
abnormalit ies imilar to those preserved in basal 
ET-K. These findings indicate that ethanol and pro- 
pylene glycol probably did not contribute to the excel- 
lent preservation efficacy of new ET-K; the hyperos- 
molarity of new ET-K  appears to have little or not 
effect on its capacity for long-term preservation. 
LPDG,  the other solut ion tested, is an extracellu- 
lar-type solution with a low potass ium concentra- 
tion. It has been reported that LPDG provides 
rel iable 24-hour canine lung preservation. 21 In this 
study, lungs preserved in LPDG did not show better  
function than those preserved in new ET-K. 
In conclusion, we demonstrated that our newly 
developed new ET-K,  which contains N-acetylcys- 
teine, nitroglycerin, and db-cAMP,  enhances 30- 
hour lung preservation. The effects of the compo- 
nents in new ET-K  need further study. These 
findings are expected to contr ibute to the improve- 
ment  of clinical lung transplantat ion.  
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